Altaris to Partner with Michelin and Acquire Majority Stake in Solesis

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement with Michelin to acquire a 51% stake of Solesis, Inc. (“Solesis”). Following closing of the transaction, Michelin will retain a…

Altaris Exits Senior Helpers

New York, NY—Altaris Capital Partners, LLC (“Altaris”) is pleased to announce that it has exited its investment in Senior Helpers through a transaction with Advocate Aurora Enterprises, a subsidiary of the not-for-profit, integrated health system Advocate Aurora Health. As part…

Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Generic Symbicort®

Pittsburgh, PA and St. Paul, MN—Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide/formoterol fumarate dihydrate products, the first generic version of Symbicort® based on…

Altaris Capital Partners to Acquire Prescription Pharmaceuticals Business from Perrigo

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire the prescription pharmaceuticals business (“Rx”) of Perrigo Company plc (NYSE; TASE: PRGO) for total consideration equal to approximately…

Cornell Capital and Trilantic North America to Acquire Fastaff and U.S. Nursing

New York, NY—Cornell Capital LLC (“Cornell Capital”) and Trilantic North America, two leading private investment firms, today announced that they have agreed to acquire Fastaff Travel Nursing® (“Fastaff”) and U.S. Nursing Corporation® (“U.S. Nursing”). This acquisition is part of a…

CSafe Global Adds New Hub Locations in Luxembourg and Italy

CSafe has engaged local partnerships to establish its first hub operation in Luxembourg and a third in Italy to support local customers. CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is once again…

Minnetronix Medical Announces Recapitalization with Altaris Capital Partners

Saint Paul, MN—Minnetronix Medical, Inc. a leading medical technology and operations partner to global medical device companies, announced today a majority recapitalization with Altaris Capital Partners, LLC. Altaris, an investment firm focused on the healthcare industry, actively manages $4.9 billion…

Kindeva Appoints Shawn Cavanagh to Board of Directors

Kindeva Drug Delivery (Kindeva) announced that Shawn Cavanagh has joined Kindeva’s Board of Directors. The appointment of Mr. Cavanagh is effective as of January 1, 2021. Mr. Cavanagh, with over 30 years of experience in the pharmaceutical services industry, will…

HealthTronics Names Bill Linder New CEO

HealthTronics has named Bill Linder its new Chief Executive Officer. Linder was formerly President of Development for Surgical Care Affiliates (SCA), a leader in outpatient surgical care with more than 230 ambulatory surgery centers across the U.S. At SCA, he…

Altaris Announces CSafe Global Recapitalization

New York, NY—Altaris Capital Partners, LLC (“Altaris”) is pleased to announce the recapitalization of CSafe Global (“CSafe”, or the “Company”) with an investor group, including funds managed by Frazier Healthcare Partners. As part of the transaction, Altaris will continue to…

Tivity Health Completes Divestiture of Nutrition Business

Company Focused on Core Healthcare Business, Strategic Growth Opportunities. Nashville, TN/PRNewswire—Tivity Health (Nasdaq: TVTY) announced today that it has completed the divestiture of its Nutrition Business, which includes Nutrisystem® and South Beach Diet®, to Kainos Capital, a leading food and…

Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products

St. Paul, MN–Kindeva Drug Delivery (Kindeva) and Breath of Life International (BOL Pharma or BOL) have signed an agreement to study the feasibility of multiple inhaled cannabinoid products. Under the agreement, Kindeva will develop novel formulations of BOL Pharma’s cannabinoidbased…